NCT00941343 - Benign Prostatic Hyperplasia in Taiwan | Biotech Hunter

Enrollment

362

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Prostatic Diseases

Interventions

DRUG

Alfuzosin (XATRAL® - SL770499)

One tablet of XATRAL® 10mg OD once a day at the end of an evening meal. The tablets had to be swallowed whole without being chewed or crushed

Trial Locations (1)

Sanofi-Aventis Administrative Office, Taipei